300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
China
Armenia
Costa Rica
Kuwait
Czech Republic
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Ireland
Paraguay
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
Germany
India
United Kingdom
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Health Care VC Funds & Investors in Denmark (August 2026)

The most active venture capital funds investing in Denmark Health Care startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Denmark Health Care startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Novo Holdings
VC Fund
36 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.9M–$135M
BioInnovation Institute
VC Fund
27 Denmark, Germany, Switzerland Convertible Note, Pre-Seed, Seed Biotechnology, Medical, Health Care $495k–$5.2M
Vaekstfonden
VC Fund
24 Denmark, United States, United Kingdom Seed, Pre-Seed Software, Information Technology, SaaS $384k–$5.3M
Export and Investment Fund
VC Fund
20 Denmark, United States, United Kingdom Seed, Series A Software, Biotechnology, Health Care $457k–$43M
PSV
VC Fund
16 Denmark, United States, United Kingdom Seed, Pre-Seed Software, Information Technology, SaaS $353k–$4.6M
Seed Capital
VC Fund
13 Denmark, United States, United Kingdom Seed, Series A Software, Health Care, SaaS $549k–$17M
Antler
VC Fund
10 Singapore, Australia, United Kingdom Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $100k–$29M
Sunstone Life Science Ventures
VC Fund
8 Denmark, Sweden, Switzerland Series A, Series B Biotechnology, Health Care, Medical $5.5M–$52M
People Ventures
VC Fund
7 Denmark, Sweden, United States Seed, Pre-Seed, Series A Software, Health Care, Artificial Intelligence $1M–$21M
byFounders
VC Fund
6 Denmark, United States, Sweden Seed, Pre-Seed, Series A Software, Artificial Intelligence, Health Care $800k–$65M
Delphinus Venture Capital
VC Fund
6 Denmark Seed, Venture - Series Unknown, Pre-Seed Health Care, Food and Beverage, Wellness $1.7M–$8.1M
West Hill Capital
VC Fund
6 United Kingdom, Denmark, Germany Series A, Seed Software, Health Care, Financial Services $2M–$15M
Oskare Capital
VC Fund
6 Italy, Denmark, United Kingdom Seed, Series A, Pre-Seed Health Care, Biotechnology, Medical $1.2M–$5.9M
Gilde Healthcare
VC Fund
6 United States, The Netherlands, Germany Series B, Series C, Series A Health Care, Biotechnology, Medical $9.5M–$135M
Forbion Capital Partners
VC Fund
5 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $16M–$180M
RA Capital Management
VC Fund
5 United States, United Kingdom, Canada Series B, Series C, Post-IPO Equity Biotechnology, Health Care, Therapeutics $27M–$240M
CVX Ventures
VC Fund
5 Denmark, Sweden, Norway Seed, Pre-Seed, Angel Manufacturing, SaaS, Gaming $44k–$5.5M
VF Venture
VC Fund
4 Denmark, United Kingdom, Iceland Seed, Series A Software, SaaS, Biotechnology $1.2M–$22M
EIR Ventures
VC Fund
4 Denmark, Sweden, United States Series A, Seed Biotechnology, Health Care, Therapeutics $20M–$73M
HealthCap
VC Fund
4 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $5.7M–$92M
Innovestor
VC Fund
4 Finland, Sweden, Denmark Seed, Pre-Seed Software, Health Care, Information Technology $204k–$4.5M
Innovation Fund Denmark
VC Fund
4 Denmark, United States Grant, Pre-Seed, Seed Software, Biotechnology, SaaS $35k–$1.6M
Chr. Augustinus Fabrikker
VC Fund
4 Denmark Series A, Series B, Series C Health Care, Software, Medical Device $16M–$80M
Karolinska
VC Fund
3 Sweden, Denmark, United States Seed, Series A Biotechnology, Health Care, Pharmaceutical $1.3M–$73M
Dawn Biopharma
VC Fund
3 United States, Denmark, France Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $15M–$165M
Omega Funds
VC Fund
3 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $14M–$208M
Alumni Ventures
VC Fund
3 United States, United Kingdom, Canada Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.5M–$79M
Sagitta Ventures
VC Fund
3 Denmark, United States, Sweden Seed, Series A, Series B Apps, Health Care, Mobile $11M–$19M
Investo Capital
VC Fund
3 Denmark, Poland Seed, Series A Sensor, Manufacturing, Medical Device $1.3M–$3.4M
Sweet Capital
VC Fund
3 United States, United Kingdom, Sweden Seed, Series A Apps, Software, Mobile $1.9M–$32M
Crowberry Capital
VC Fund
3 Iceland, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Health Care $400k–$17M
Sofinnova Partners
VC Fund
3 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.6M–$109M
Ugly Duckling Ventures
VC Fund
3 Denmark, Sweden, Finland Seed, Pre-Seed, Venture - Series Unknown Software, Information Technology, Artificial Intelligence $876k–$7.5M
DSM Venturing
VC Fund
3 United States, Canada, Israel Series A, Series B Health Care, Biotechnology, Manufacturing $3.5M–$32M
Crista Galli Ventures
VC Fund
3 United Kingdom, United States, Sweden Seed, Pre-Seed, Series A Health Care, Medical, Wellness $655k–$14M
Ysios Capital
VC Fund
3 Spain, United States, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Medical $3.8M–$135M
Bioqube Ventures
VC Fund
3 United States, France, Norway Seed, Series A, Series B Biotechnology, Therapeutics, Life Science $4M–$108M
Idinvest Partners
VC Fund
2 France, United States, Spain Series B, Series A Biotechnology, Health Care, Software $3.3M–$66M
CAPNOVA
VC Fund
2 Denmark, United States, India Seed, Pre-Seed Software, Information Technology, B2B $147k–$2.4M
CBC Investment Group
VC Fund
2 Sweden, Denmark, Germany Seed, Series B Software, Biotechnology, SaaS
The Footprint Firm
VC Fund
2 Denmark, Spain, Norway Seed, Pre-Seed, Series A Software, Renewable Energy, Energy Management
Unconventional Ventures
VC Fund
2 Sweden, United Kingdom, Denmark Seed, Pre-Seed, Series A Health Care, Software, Wellness
Wellcome Trust
VC Fund
2 United States, United Kingdom, France Grant, Series C Biotechnology, Health Care, Medical $1.6M–$127M
Balderton Capital
VC Fund
2 United Kingdom, United States, Germany Series A, Series B, Series C Software, Financial Services, Artificial Intelligence $5M–$150M
Inkef
VC Fund
2 The Netherlands, United States, Germany Series A, Series B, Seed Biotechnology, Health Care, Medical $2.8M–$86M
Inventure
VC Fund
2 Finland, Sweden, United States Seed, Series A, Series B Software, Information Technology, Health Care $549k–$25M
NOON Ventures
VC Fund
2 Denmark Seed, Series A Biotechnology, AgTech, Farming
M Ventures
VC Fund
2 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Digital Health Ventures
VC Fund
2 Germany, Denmark, France Seed, Series A, Series B Health Care, Fitness, Wellness $2.2M–$12M
Heartcore Capital
VC Fund
2 Denmark, United States, Germany Seed, Series A, Series B Software, Artificial Intelligence, FinTech $1.3M–$58M
Access all 370 VC funds in Denmark Health Care startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 36 investments in Denmark Health Care startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 370
  • Round size: Series A $9.9M–$133M; Series B $12M–$135M; Series C $30M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Tarveda Therapeutics — Developing Pentarins to make a difference in the treatment of patients with solid tumor malignancies
  • Tarsa Therapeutics — Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
  • Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
Show all investments...

BioInnovation Institute
VC Fund · Copenhagen, Hovedstaden, Denmark · 27 investments in Denmark Health Care startups

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Convertible Note, Pre-Seed, Seed
  • Geography: Denmark, Germany, Switzerland

Investor stats

  • Total investments: 92
  • Round size: Seed $532k–$1.6M; Pre-Seed $516k–$5.2M; Convertible Note $495k–$1.6M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
  • metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Show all investments...

Vaekstfonden
VC Fund · Hellerup, Hovedstaden, Denmark · 24 investments in Denmark Health Care startups

Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 209
  • Round size: Seed $830k–$5.3M; Pre-Seed $384k–$1.2M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Deskwolf — Desk Wolf helps SMEs to take advantage of Facebook to generate more sales, more customers, and promote their business in an efficient manner.
  • Advalight — Advalight is a young, dynamic company dedicated to providing high-quality laser equipment for dermatological treatments. The company has patented an innovative technology for use in the removal of vascular lesions, acne treatment, skin rejuvenation and many other skin-enhancing procedures. The ground-breaking product was launched the summer 2014.Advalight is based on five years of scientific work in the Physics Department at the Technical University of Denmark. The founders include two PhDs and it is their research that forms the basis of Advalight. The company's main focus is on research and development and with the right external partners we believe that the market for dermatological lasers will be transformed. Advalight is therefore seeking collaboration with external partners with established distribution and sales channels.
  • CrossEyes — CrossEyes is a Danish optician chain founded in Aarhus in 2010. Our frames are only available in CrossEyes stores and the designs are inspired by current trends and the Scandinavian simplicity.We believe that glasses are not just a tool to see better: They are a fashion accessory and reflects personality and individual style. We get newcollections 10-12 times annually to make sure there’s always news on the shelves – from the everyday classic Original frame to the colorful and trendy Limited.Our vision is to change the eyewear and optical world. We offer a unique customer experience through stunning eyewear, honest pricing, and legendary service. We do this by putting the customer first in every aspect of our business, as we see our customers as ambassadors for our glasses. We strive to give them the best service possible – every time.
Show all investments...

Export and Investment Fund
VC Fund · Hellerup, Hovedstaden, Denmark · 20 investments in Denmark Health Care startups

Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 136
  • Round size: Seed $457k–$11M; Series A $5.9M–$43M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
  • MATR Foods — MATR Foods is a food-tech startup that provides fungi-based food ingredients offering dishes produced from fungi like mushrooms, vegetables, and fruits.
  • VentriJect — VentriJect is a is a research facility that incorporates measuring cardiorespiratory fitness into everyone's checkup. They estimate respiratory fitness, which is a simple process. As a health indicator, people can increase their cardiorespiratory fitness. They have compiled a list of some of the other pertinent articles that relate to thesignificance of VO2-max measurement.
Show all investments...

PSV
VC Fund · Lyngby, Hovedstaden, Denmark · 16 investments in Denmark Health Care startups

PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 149
  • Round size: Seed $500k–$4.6M; Pre-Seed $353k–$2.5M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $42M in 2020

Portfolio highlights

  • Woba — Woba is a SaaS aiming to support a stress-free work environment and minimise sick leave.
  • Jabbr — Jabbr allows to capture boxing matches with a virtual video production.Its goal is to make video production and advanced performance analytics in combat sports available to anyone with a smartphone.
  • eloomi — eloomi is an LMS platform for your workplace to train, retain & engage employees. Explore impactful learning & development today.
Show all investments...

Seed Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 13 investments in Denmark Health Care startups

Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Series A
  • Geography: Denmark, United States, United Kingdom

Investor stats

  • Total investments: 191
  • Round size: Seed $549k–$5.2M; Series A $3.8M–$17M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $73M in 2021

Portfolio highlights

  • eloomi — eloomi is an LMS platform for your workplace to train, retain & engage employees. Explore impactful learning & development today.
  • Flatpay — Flatpay's fair, flat-rate pricing simplifies payments & cuts costs. Benefit from our comprehensive solution & superior customer service. Join us now!
  • Asante Solutions — Asante Solutions was founded more than a decade ago in Denmark. While there, they developed close relationships with a select group of European-based venture capitalists. Backed with venture seed money, they began early stage development of an insulin delivery device that would ultimately become their first product - the Pearl Insulin Pump.
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 10 investments in Denmark Health Care startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Singapore, Australia, United Kingdom

Investor stats

  • Total investments: 2216
  • Round size: Seed $159k–$4.6M; Pre-Seed $100k–$645k; Series A $4.1M–$29M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $72M in 2024

Portfolio highlights

  • Praktiki — Praktiki is building the "Decision Layer" for medicine.While medical knowledge doubles every 73 days, frontline clinicians struggle to translate guidelines into practice. Current AI search tools excel at surfacing public data from clinical trials, but fail to capture "how" experts apply that evidence in real-world scenarios.Praktiki fills this gap. We utilise an AI Agentic Creator Engine to capture tacit specialist reasoning and fuse it with public evidence. This feeds a proprietary Expert Knowledge Graph that powers: 1) Microlearning: Case-based modules created 10x faster and which are 170% more effective than traditional education 2) AI Expert Guidance: Real-time decision support synthesising evidence with expert implementation strategies.2025 Traction - our MVP proved that solving the expertise gap drives high engagement: - Registered >10% of UK GPs - 60,000+ modules completed with an 85% completion rate - 51% month-over-month growth - Market-leading NPS of 83We are building a compounding data moat to expand beyond education into clinical intelligence and healthcare data solutions.
  • Mast — Mast is the cloud-native, fully configurable loan origination platform empowering lenders to process applications faster and smarter. We make lending better, smoother and faster.
  • Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
Show all investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 8 investments in Denmark Health Care startups

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Denmark, Sweden, Switzerland

Investor stats

  • Total investments: 61
  • Round size: Series A $5.5M–$44M; Series B $9.6M–$52M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $94M in 2019

Portfolio highlights

  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

People Ventures
VC Fund · Taastrup, Hovedstaden, Denmark · 7 investments in Denmark Health Care startups

We invest ourselves and money into early-stage founders. Operational VC based in Copenhagen, backing pre-seed and seed tech companies across the Nordics.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Denmark, Sweden, United States

Investor stats

  • Total investments: 36
  • Round size: Seed $1.1M–$19M; Pre-Seed $1M–$1.6M; Series A $3.5M–$21M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • Alrik — Turn your logistics into a competitive advantage and take control of your emissions. We help building material suppliers revolutionize their workflows.
  • Passendo — Passendo is the leading email ad server and platform for publishers and advertisers: unlock new revenue with powerful targeting and delivery.
  • Pandektes — Legal Research, redefined.
Show all investments...

byFounders
VC Fund · Copenhagen, Hovedstaden, Denmark · 6 investments in Denmark Health Care startups, 17 in the past 12 months

byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Denmark, United States, Sweden

Investor stats

  • Total investments: 124
  • Round size: Seed $1.5M–$9.4M; Pre-Seed $800k–$4.2M; Series A $6.1M–$65M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $117M in 2021

Portfolio highlights

  • Visoid — Render your 3D models with ease! Quick and easy rendering software for architects, powered by AI. Try Visoid for free!
  • Verda (formerly DataCrunch) — DataCrunch is a cloud service provider which facilitates utilization and integration of state of the art AI/ML models
  • Spiral Hydrogen — All-in-one, bubble-free centrifugal electrolyzer with an embedded axial flux generator that sets a new standard in efficiency and simplicity.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Delphinus Venture Capital
VC Fund · 6 investments in Denmark Health Care startups, 12 in the past 12 months

Delphinus Venture Capital is a venture investment management firm.

Show more...

Investment focus

  • Industry: Health Care, Food and Beverage, Wellness
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Denmark

Investor stats

  • Total investments: 12
  • Round size: Seed $1.7M–$3.4M; Venture - Series Unknown $1.9M–$8.1M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Alcolase — Alcolase is developing a liposomal enzyme system designed to support alcohol metabolism in the stomach. Copenhagen-based biotech backed by Ada Ventures and Delphinus Venture Capital.
  • Oktogrid — Electrification is taking place at a rate, where conventional methods for inspection, maintenance, and congestion management no longer match the new energy scenario. Distribution transformers are ageing blind spots today with no access to online, real-time performance data. This is because getting access to data is hard. We have solved this problem.
  • Ardos — Ardos is a developer of radiotherapy software designed to enhance cancer treatment.
Show all investments...

West Hill Capital
VC Fund · London, England, United Kingdom · 6 investments in Denmark Health Care startups

West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.

Show more...

Investment focus

  • Industry: Software, Health Care, Financial Services
  • Stage:Series A, Seed
  • Geography: United Kingdom, Denmark, Germany

Investor stats

  • Total investments: 60
  • Round size: Seed $2.6M–$6M; Series A $2M–$15M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Silicon MicroGravity — Silicon Microgravity Limited is a spin-out from Cambridge University. The underpinning sensor technology was developed through a collaboration with BP plc and provides a breakthrough in the management of oil and gas reservoirs. The technology has been developed in Cambridge University’s Nanoscience Centre primarily funded by BP and Innovate UK.
  • ATLANT 3D — Micro and nanodevices are built and tested within days instead of months or years.
  • Formalize — Formalize delivers a cloud-based compliance operations platform designed for governance, risk, and control workflows, enabling businesses to automate processes around frameworks such as NIS2, DORA, ISO 27001, and GDPR. The platform lets users centralize risk and incident tracking, manage third-party audits and controls, and build customizeddashboards and workflows across compliance, supplier management, and governance.
Show all investments...

Oskare Capital
VC Fund · Paris, Ile-de-France, France · 6 investments in Denmark Health Care startups

Oskare Capital is a venture capital firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, Denmark, United Kingdom

Investor stats

  • Total investments: 9
  • Round size: Seed $1.2M–$3.4M; Series A $4.7M–$5.9M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • Leva Clinic — Leva Clinic offers health care services for people with chronic pain. Their medical services include back pain, cancer pain, endometriosis, facial pain, fibromyalgia, joint pain, knee pain, multiple sclerosis, sciatica, and so on.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Herbolea Biotech — Unique bio-processing technologies NATURAL, SOLVENT-LESS Botanical extraction Learn more
Show all investments...

Gilde Healthcare
VC Fund · Utrecht, Utrecht, The Netherlands · 6 investments in Denmark Health Care startups, 7 in the past 12 months

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, The Netherlands, Germany

Investor stats

  • Total investments: 131
  • Round size: Series A $9.5M–$63M; Series B $15M–$135M; Series C $21M–$75M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $786M in 2023

Portfolio highlights

  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
  • GT Medical Technologies — GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors.
  • Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 5 investments in Denmark Health Care startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 208
  • Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $19M–$120M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Inflazome — Situs gacor premium Megawin188 paling banyak di minati oleh semua kalangan karena pecah selayar tanpa henti dan memiliki tampilan yang sangat memanjakan mata.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

RA Capital Management
VC Fund · Boston, Massachusetts, United States · 5 investments in Denmark Health Care startups

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Post-IPO Equity
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 518
  • Round size: Series B $27M–$152M; Series C $44M–$183M; Post-IPO Equity $35M–$240M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
  • Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
  • Kinaset Therapeutics — Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
Show all investments...

CVX Ventures
VC Fund · Köpenhamn, Vasternorrlands Lan, Sweden · 5 investments in Denmark Health Care startups

Together with our partners, we invest capital and skills in the most promising growth companies and make a difference for Nordic businesses.

Show more...

Investment focus

  • Industry: Manufacturing, SaaS, Gaming
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Denmark, Sweden, Norway

Investor stats

  • Total investments: 82
  • Round size: Seed $100k–$5.5M; Pre-Seed $44k–$2.3M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Bookboost — Communicate with your guests without any effort and across the entire guest journey. Our Multi-Channel CRM and Unified Inbox are here to help you enhance your guest experience.
  • TastyUrban — TastyUrban is in the process of developing a new generation of restaurant usage and strategy.
  • SmartPlay — SmartPlay is a platform offering game marketing, development, and full game acquisition services.
Show all investments...

VF Venture
VC Fund · Hellerup, Hovedstaden, Denmark · 4 investments in Denmark Health Care startups

Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Seed, Series A
  • Geography: Denmark, United Kingdom, Iceland

Investor stats

  • Total investments: 30
  • Round size: Seed $1.2M–$9.1M; Series A $3.5M–$22M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Rokoko — Rokoko | Affordable high-end motion capture and animation tools for body, hand, and face capture + software with native integrations for all major animation software and game engines
  • Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
  • Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
Show all investments...

EIR Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in Denmark Health Care startups

EIR Ventures is a new Life Science Venture Group in the Nordics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed
  • Geography: Denmark, Sweden, United States

Investor stats

  • Total investments: 13
  • Round size: Series A $20M–$73M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $143M in 2021

Portfolio highlights

  • ArgusEye — ArgusEye is a biotechnology company that provides sensor solutions for real-time detection of biological systems and processes. ArgusEye's patented sensor technology is the result of extensive academic research and is based on nanoplasmonic sensing with fiber optics. By adding customized receptors, ArgusEye can offer flexible and sensitivesensing systems for a variety of targets.
  • Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
  • Hoba Therapeutics — Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in Denmark Health Care startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 133
  • Round size: Series A $5.7M–$85M; Series B $12M–$92M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $209M in 2019

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Denmark Health Care startups

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 89
  • Round size: Seed $478k–$4.5M; Pre-Seed $204k–$2M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2020

Portfolio highlights

  • Retailgrid — Agentic AI pricing platform for mid-market retailers. Turn messy retail data into structured, explainable price decisions in days, not months.
  • Bahn Express — Euroopan nopein autojen kuljetus. Autoliikkeille, autokauppiaille ja kalustonhallintaan. Euroopan halki 72 tunnissa.
  • Cornea Sense — CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care.
Show all investments...

Innovation Fund Denmark
VC Fund · Copenhagen, Hovedstaden, Denmark · 4 investments in Denmark Health Care startups

Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Grant, Pre-Seed, Seed
  • Geography: Denmark, United States

Investor stats

  • Total investments: 96
  • Round size: Seed $66k–$1.3M; Grant $35k–$1.2M; Pre-Seed $64k–$1.6M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Prezio — Access comprehensive electricity tariff data across Europe via one API
  • PerPlant — PerPlant gives tractors the ability to see every plant. AI-powered cameras that cut input costs by 50% on average.
  • SureShot — SureShot empowers you and your audience to become video co-creators. With our cutting-edge AI, capture, edit, and share electrifying videos that amplify the essence of every event.
Show all investments...

Chr. Augustinus Fabrikker
VC Fund · Copenhagen, Hovedstaden, Denmark · 4 investments in Denmark Health Care startups

Chr. Augustinus Fabrikker operates as an investment management firm with a core focus on dedicated ownership of Danish businesses. Founded in 1750, Chr. Augustinus Fabrikker has a capital base of more than 30 billion, a significant player in the Danish business community. It is owned by the Augustinus Foundation, which is one of Denmark'slargest cultural foundations, and also makes significant contributions to research and social initiatives.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical Device
  • Stage:Series A, Series B, Series C
  • Geography: Denmark

Investor stats

  • Total investments: 18
  • Round size: Series A $16M–$27M; Series B $21M–$78M; Series C $44M–$80M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Eupry — Be in full control of your temperature compliance at all times. Collect temperature monitoring, mapping, and calibration in one GxP-compliant solution.
  • Podimo — Podimoa is an open podcast platform that offers a subscription service for creators. Founded in 2019, Podimo is a podcast and short-form audio platform which offers personalized recommendations to listeners, while offering creators a share of revenue via premium subscriptions. Co-founded by Morten Strunge, Nikolaj Koppel, Andreas Sachse, EvaLægdsgaard, and Sverre Dueholm, Podimo is hoping to capitalize on the rise in consumption in podcasts.
  • Dawn Health — Dawn Health is a digital health company offering life-changing digital health therapies driving improved patient outcomes beyond the pill. The company is enabling to design, develop, and service medical device software. They help people live better and longer lives through technology and aim to accelerate digital health globally through strategicconsulting and the development of innovative digital health products together with their partners. As MedTech specialists, they create life-changing solutions with a strategic focus on digital health, SaMD, GxP software, and IoT within healthcare. Dawn Health envisions a time where digital health solutions will revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being. The company has a global ambition to be the preferred Digital Health Partner to the life science industry, and through their partnerships and ventures, to impact one million lives by 2030 through digital interventions.
Show all investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 3 investments in Denmark Health Care startups

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 32
  • Round size: Series A $1.3M–$73M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
  • Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Show all investments...

Dawn Biopharma
VC Fund · Wilmington, Delaware, United States · 3 investments in Denmark Health Care startups, 6 in the past 12 months

Dawn Biopharma is a global investment firm of KKR.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United States, Denmark, France

Investor stats

  • Total investments: 14
  • Round size: Seed $15M–$32M; Series A $17M–$165M; Series B $115M–$135M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
  • Expedition Therapeutics — Redefining Care. Advancing COPD and Other Respiratory Therapies. Expedition Therapeutics is developing novel treatments for inflammatory and respiratory diseases with the potential to fundamentally transform patient care worldwide. ABOUT US At Expedition Therapeutics, we believe that disease-controlling treatments that address fundamental disease mechanisms should be the new standard for chronic obstructive pulmonary disease (COPD). Our
Show all investments...

Omega Funds
VC Fund · Boston, Massachusetts, United States · 3 investments in Denmark Health Care startups

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 161
  • Round size: Series A $16M–$187M; Series B $37M–$162M; Series C $14M–$208M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Attenua — 100% satisfaction guaranteed. Hassle-free shopping. We help you find the right domain name.
  • Andrew Alliance — OneLab is laboratory software to design and execute liquid handling protocols. Pipette+ for manual liquid handling pipetting and Andrew+ the pipetting robot
  • Chord Therapeutics — Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. We are advancing our lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG).
Show all investments...

Alumni Ventures
VC Fund · Manchester, New Hampshire, United States · 3 investments in Denmark Health Care startups

Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 2214
  • Round size: Seed $1.5M–$10M; Series A $5.5M–$35M; Series B $12M–$79M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Tabs — Tabs provides AI-powered accounts receivable software to save time analyzing contracts, improve cash flow, and avoid billing errors.
  • Enact — Enact is a leading solar energy and solar software company serving homeowners, businesses, and installers. Get a free quote or request a demo today!
  • Beam — Smarter employee benefits including dental, vision, life, disability, and supplemental health. Our plans are easy to understand, implement, and use.
Show all investments...

Sagitta Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Health Care startups

Sagitta Ventures invests in early-stage companies in the Nordics and provides long-term capital backing for well-managed businesses that are seeking minority investors without a defined exit horizon.

Show more...

Investment focus

  • Industry: Apps, Health Care, Mobile
  • Stage:Seed, Series A, Series B
  • Geography: Denmark, United States, Sweden

Investor stats

  • Total investments: 7
  • Round size: Series A $11M–$19M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Cerebriu — Cerebriu is a health tech company developing machine learning in medical imaging that improves workflow efficiency and quality in radiology.Its software solution Cerebriu Apollo achieves the company's aim by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of thediagnostic process. The company covers findings of the brain, starting with brain MRI, including stroke, bleeds, and tumors, following MS, dementia, and TBI in brain CT.
  • Howtorobot.com — HowToRobot is a global automation-marketplace platform that helps companies evaluate, source, and implement robotic and automation solutions. The platform enables users to describe the process they wish to automate, broadcast a “market request” to over 20,000 vetted suppliers, receive tailored quotes quickly, and compare options for budget, ROI,and risk.HowToRobot also offers independent advisory services—either via its own expert team or through its partner network—to guide companies from initial planning through implementation and help underserved firms navigate automation adoption. Additionally, the platform delivers educational content including articles on robot types, automation applications, and industry insights to help manufacturing or operations teams build internal knowledge.
  • Donkey Republic — Donkey Republic enables cities to create a better quality of life, getting people on two wheels. We provide a flexible, reliable and open bike sharing platform that adjusts to the needs of the city, and integrates to rest of the public transport. We provide bike- and ebike sharing service using virtual or physical docking stations, for both short-and long term rentals.
Show all investments...

Investo Capital
VC Fund · Aalborg, Nordjylland, Denmark · 3 investments in Denmark Health Care startups

Investo Capital is a Danish venture capital firm based in Aalborg. They invest in carefully selected Danish early-growth companies within tech business areas in the broad sense. The target group is innovative companies with proof of business, strategic thinking, and strong growth prospects in Denmark. Strategic corporate concepts and competentmanagement are essential features. The investment focus is Technology, IT, SAAS- and med-tech.

Show more...

Investment focus

  • Industry: Sensor, Manufacturing, Medical Device
  • Stage:Seed, Series A
  • Geography: Denmark, Poland

Investor stats

  • Total investments: 10
  • Round size: Seed $1.3M–$3.4M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Dryp — Dryp provides an IoT-enabled wireless sensor that collects real-time water data. By combining data science and AI, the company turns real-time data into valuable insights, wastewater into resource, and optimize city systems without leaving a climate footprint. It also helps clients to optimize water facilities by detecting leaks or monitoring howwater is being distributed across the network and allowing them to make more informed decisions about water management.The company was founded in 2019 and is headquartered in Copenhagen, Denmark.
  • VentriJect — VentriJect is a is a research facility that incorporates measuring cardiorespiratory fitness into everyone's checkup. They estimate respiratory fitness, which is a simple process. As a health indicator, people can increase their cardiorespiratory fitness. They have compiled a list of some of the other pertinent articles that relate to thesignificance of VO2-max measurement.
  • Brainreader — Brainreader was founded in 2011 as a spin-off from Aarhus University by a team of highly skilled and motivated individuals with complementary competencies dedicated to bringing our brain image analysis technology to the clinical market.Research done by The European Medicines Agency’s shows, that baseline measurement of low hippocampalvolume (i.e., atrophy) is a supportive indicator of evolution from cognitive impairment to Alzheimer´s disease and dementia. The Brainreader software is developed on the basis of such research.Brainreader wants to be a dominant player in the market for structural analysis of MRI’s. We want Neuroreader™ to be the routine tool of choice for physicians and MRI clinics all over the world when assessing structural MRI’s.Brainreader is currently bringing our new cutting-edge software tool, Neuroreader™, to the clinical market. It is our vision that Brainreader will deliver objective, precise, and personal analysis of brain scans. Ultimately increasing quality of life for the patient and significantly reducing disease-related costs for society.
Show all investments...

Sweet Capital
VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in Denmark Health Care startups

Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).

Show more...

Investment focus

  • Industry: Apps, Software, Mobile
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Sweden

Investor stats

  • Total investments: 65
  • Round size: Seed $1.9M–$5M; Series A $3M–$32M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Pachama — Harnessing AI to drive carbon capture and protect global forests
  • Aula Education — Aula's created by educators to make every learning experience truly engaging. See how our simple, social platform can transform your digital learning environment.
  • Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Crowberry Capital
VC Fund · Reykjavík, Gullbringusysla, Iceland · 3 investments in Denmark Health Care startups

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

Show more...

Investment focus

  • Industry: Software, Gaming, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Iceland, Denmark, Finland

Investor stats

  • Total investments: 50
  • Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
  • Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
  • Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 3 investments in Denmark Health Care startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 329
  • Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
  • Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
Show all investments...

Ugly Duckling Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Health Care startups, 6 in the past 12 months

At Ugly Duckling Ventures, we make capital, know-how, and real-world application available to Nordic ventures at the seed & pre-seed stage. We are operational by nature and want to get in the grind as we excel at getting early-stage ventures ready for scale.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Denmark, Sweden, Finland

Investor stats

  • Total investments: 20
  • Round size: Seed $876k–$5.5M; Pre-Seed $917k–$1.7M; Venture - Series Unknown $1.1M–$7.5M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Skyfora — Skyfora delivers sub-kilometer insights, nowcasts, and probabilistic forecasts so your teams can plan with confidence, no matter the weather.
  • P-Secure — P-Secure is Europe's only automated platform for EU-compliant background checks. Screening employees, applicants and suppliers in minutes.
  • Financial News Systems — Real-time News for Investment Professionals
Show all investments...

DSM Venturing
VC Fund · Heerlen, Limburg, The Netherlands · 3 investments in Denmark Health Care startups

Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 94
  • Round size: Series A $3.5M–$32M; Series B $5.6M–$30M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • Athian — Funding livestock sustainability via a connected carbon marketplace.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Meala Foodtech — Revolutionary texturized plant proteins that replace eggs and hydrocolloids. Clean-label, allergen-free solutions for baking, savory foods, and dressings.
Show all investments...

Crista Galli Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Health Care startups

Physician-led venture capital investing in TechBio, DeepTech Healthcare, and Digital Health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Wellness
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Sweden

Investor stats

  • Total investments: 37
  • Round size: Seed $960k–$8.5M; Pre-Seed $655k–$2.5M; Series A $5.7M–$14M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
  • Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
  • Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Show all investments...

Ysios Capital
VC Fund · San Sebastian, Pais Vasco, Spain · 3 investments in Denmark Health Care startups

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Spain, United States, Switzerland

Investor stats

  • Total investments: 81
  • Round size: Series A $3.8M–$62M; Series B $20M–$135M; Series C $27M–$80M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
Show all investments...

Bioqube Ventures
VC Fund · Hasselt, Limburg, Belgium · 3 investments in Denmark Health Care startups

Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States, France, Norway

Investor stats

  • Total investments: 18
  • Round size: Seed $5.7M–$24M; Series A $4M–$76M; Series B $23M–$108M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • Spica Therapeutics — Spica Therapeutics is a pioneering biotech company dedicated to transforming macrophage biology into breakthrough therapies for patients across multiple therapeutic areas. Leveraging its proprietary functional macrophage fingerprinting technology, Spica identifies and selectively targets disease-relevant macrophage sub
  • Primmune Therapeutics — Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 2 investments in Denmark Health Care startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 254
  • Round size: Series A $3.3M–$27M; Series B $7.8M–$66M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • Botify — Search engines miss about half the content on enterprise websites. Uncover those hidden opportunities with Botify, the leading enterprise SEO platform!
  • LumApps — LumApps is the only intranet packaged solution that enables employees to feel connected to their organization and engaged in their work from anywhere by delivering a modern, smart digital headquarters that empowers your employees to design a work experience that works for them.
  • Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Show all investments...

CAPNOVA
VC Fund · Aarhus, Midtjylland, Denmark · 2 investments in Denmark Health Care startups

They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.

Show more...

Investment focus

  • Industry: Software, Information Technology, B2B
  • Stage:Seed, Pre-Seed
  • Geography: Denmark, United States, India

Investor stats

  • Total investments: 24
  • Round size: Seed $147k–$2.4M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Ulobby — Ulobby is an automated tool for stakeholder management and political monitoring
  • Mechanic Miner — Mechanic Miner is a 2D construction/survival game with mechanical steam-powered machines. You are stranded on a strange and forbidding planet, where survival is made difficult by hostile animals and plant life. From your home world you did bring a multitool, which is able to craft any kind of machine part - provided the requisite rawmaterials can be found. Relying solely on the technology you brought, you set out to explore a whole world. You can progress through the game by acquiring new types of steam-powered technology elements, that are necessary to delve deeper into the diverse biomes of the planet, and perhaps, ultimately, discover the means to escape. You can construct any kind of machine of your own design - and any kind of machine can be simulated by the game's physics engine - and of course, designs can be shared with your friends.
  • ResoTher Pharma — ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin 1A as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role.
Show all investments...

CBC Investment Group
VC Fund · Gothenburg, Vastra Gotaland, Sweden · 2 investments in Denmark Health Care startups

CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Series B
  • Geography: Sweden, Denmark, Germany

Investor stats

  • Total investments: 12
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • GLX Analytix — GLX Analytix is ​​a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
  • Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
  • Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
The Footprint Firm
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Denmark Health Care startups

The Footprint Firm is an advisory and investment company with a sole focus on sustainability.

Show more...

Investment focus

  • Industry: Software, Renewable Energy, Energy Management
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Denmark, Spain, Norway

Investor stats

  • Total investments: 22
  • Lead/follow: no public data

Portfolio highlights

  • LastSwab — LastSwab launched May 2019 through the crowdfunding platform Kickstarter. At $16 a swab, LastSwab is meant to last at least 1,000 uses and is the easy-to-clean, reusable alternative to the abundant waste caused by single-use swabs around the globe. The tip of the swab is made from medical silicone and nylon and comes in a biodegradable case made ofa corn-based material. LastSwab can be easily cleaned using soap and water and is also dishwasher safe. It comes in a standard swab for cleaning and a pointed swab for makeup application. Be the change and #SwabYourHabits.
  • Nordic Salt Cycle — Nordic Salt Cycle provides a scalable melting salt methods for collecting important and strategic minerals from end-of-life products.
  • GreenShift Technologies — GreenShift Technologies is a sustainable computing platform designed to optimize cloud infrastructure and applications.
Show all investments...

Unconventional Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Denmark Health Care startups

Unconventional Ventures invests in startups in the pre-seed and seed stage led by diverse founders identifying as women, people of color, immigrants and/or LGBTQ+, building scalable impact tech companies in the Nordics and beyond.

Show more...

Investment focus

  • Industry: Health Care, Software, Wellness
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Sweden, United Kingdom, Denmark

Investor stats

  • Total investments: 16
  • Lead/follow: no public data

Portfolio highlights

  • Flox Intelligence — Wildlife intelligence for critical infrastructure.
  • AIRMO — Airmo is a space tech company that offers an independent data source that locates, quantifies, and tracks carbon dioxide and methane emissions through a small satellite constellation.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
Show all investments...

Wellcome Trust
VC Fund · London, England, United Kingdom · 2 investments in Denmark Health Care startups, 9 in the past 12 months

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Grant, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 125
  • Round size: Grant $1.6M–$10M; Series C $10M–$127M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $319M in 2018

Portfolio highlights

  • Lario Therapeutics — Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
  • Wysa — Use Wysa to vent or just talk through negative thoughts and emotions. Let it help you cope with pandemic anxiety and lockdowns. It is anonymous, safe and free.
  • Ineffable Intelligence — Making first contact with superintelligence.
Show all investments...

Balderton Capital
VC Fund · London, England, United Kingdom · 2 investments in Denmark Health Care startups

In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.

Show more...

Investment focus

  • Industry: Software, Financial Services, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 405
  • Round size: Series A $5M–$30M; Series B $9.6M–$100M; Series C $15M–$150M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $615M in 2024

Portfolio highlights

  • Exein — Exein develops embedded cybersecurity solutions designed to secure Internet of Things (IoT) and connected devices. The company provides a platform that integrates security directly into the firmware of embedded systems, enabling real-time threat detection, monitoring, and response. Exein’s technology focuses on runtime protection and behavioranalysis at the edge, helping manufacturers secure devices without requiring major hardware changes or external software agents. Its solution is compatible with widely used real-time operating systems (RTOS) and Linux-based environments, allowing for flexible integration across different devices. The company also offers tools for vulnerability assessment and threat intelligence tailored for firmware-level defense. Exein supports developers with APIs and SDKs to incorporate security features during the product development phase. Through its platform, the company addresses growing security risks in critical sectors such as automotive, industrial automation, and consumer electronics.
  • Writer — WRITER is the enterprise AI agent platform trusted by Fortune 500 companies, built to help teams execute and scale on-brand, compliant work.
  • Wayve — Wayve are pioneering an AI-centric approach to self-driving, inspired by our vision of a smarter, safer and more sustainable world.
Show all investments...

Inkef
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Denmark Health Care startups

SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: The Netherlands, United States, Germany

Investor stats

  • Total investments: 89
  • Round size: Seed $2.8M–$24M; Series A $3.2M–$42M; Series B $8.2M–$86M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $585M in 2016

Portfolio highlights

  • Silverflow — Silverflow offers global payment technology to power financial institutions.
  • Provable Markets — A comprehensive suite of trading & trade management solutions for the front, middle, and back office
  • Quantum Motion — Quantum Motion delivers scalable silicon-based quantum computing using standard semiconductor manufacturing technology.
Show all investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Denmark Health Care startups

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 176
  • Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $169M in 2022

Portfolio highlights

  • Leetify — We help gamers identify their weaknesses, work on those weaknesses and track their progression.
  • UpCloud — World's fastest cloud servers with a 100% uptime SLA! Sign up for a free trial today.
  • ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
Show all investments...

NOON Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Denmark Health Care startups

Noon Ventures is a Copenhagen-based, early-stage venture investor established in 2020. We invest in proven transformative technologies with the potential to impact environmental or climate challenges.

Show more...

Investment focus

  • Industry: Biotechnology, AgTech, Farming
  • Stage:Seed, Series A
  • Geography: Denmark

Investor stats

  • Total investments: 6
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Agrobiomics — Agrobiomics is a danish Agritech start-up, harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
  • Enduro Genetics — Bioproduction can be difficult to scale to large cultivation volumes while keeping titers high. By applying game-changing synthetic biology technology, Enduro Genetics empowers our partner companies to maximize performance of all cells cultivated from their production strains.
  • Lotus Microsystems — Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug andplay solutions enable our customers to innovate their electronics without worrying about power supply units.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Denmark Health Care startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 174
  • Round size: Seed $2.4M–$24M; Series A $5.6M–$50M; Series B $15M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • ApoGen Biotechnologies — Explore fast payout casinos that deliver winnings instantly or under 24 hours. List of the best payout casinos to get same day winnings.
Show all investments...

Digital Health Ventures
VC Fund · Berlin, Berlin, Germany · 2 investments in Denmark Health Care startups

Digital Health Ventures (DHV) is a sector-focused Venture Capital Fund based in Berlin. They are experienced early-stage investors with a track record that includes several strong European healthcare innovators. Our mission is to build a sustainable Digital Health ecosystem. They actively support portfolio entrepreneurs and leverage our networks intech and healthcare. They work together closely and find joint solutions. They invest in startups which will play a significant role in healthcare and that want a strong partner during this journey.

Show more...

Investment focus

  • Industry: Health Care, Fitness, Wellness
  • Stage:Seed, Series A, Series B
  • Geography: Germany, Denmark, France

Investor stats

  • Total investments: 9
  • Round size: Seed $2.2M–$2.5M; Series A $9M–$12M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Wefight — Wefight is an open door for patients treated outside clinical settings. It makes it possible to offer services and facilitates the collect of data in real life. Our goal: to secure patients at home and save time for care teams.
  • TeleClinic — TeleClinic's vision is to provide everyone with a full first-stop-shop for all health related questions. First and foremost, this means guaranteeing first-class medical care at all times. They want to do that with the help of digital possibilities and they work on that every day.
  • Handl Health — Making healthcare price transparency simple, insightful and actionable.
Show all investments...

Heartcore Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Denmark Health Care startups

Heartcore Capital invests in companies re-enchanting the world through technology.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Denmark, United States, Germany

Investor stats

  • Total investments: 206
  • Round size: Seed $1.3M–$12M; Series A $3.4M–$27M; Series B $9.6M–$58M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $250M in 2021

Portfolio highlights

  • PhaseTree — Materials design simulation company - PhaseTree ApS
  • TrapLight Games — A hard-hitting mobile game studio from Finland. Traplight is a premium mobile games studio with 10+ years of game development expertise at the highest level. Our ambition is to create world class, chart topping, scalable game services.
  • Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
Show all investments...

Health Care VC funding in Denmark at a glance

Stats across 485 deals from 370 investors.

370
investors
in Denmark Health Care startups
485
deals
in Denmark Health Care startups
$2.8M
median round
in Denmark Health Care startups
54%
lead investors
lead at least one round
20%
Seed
most common funding stage

Access all 370 VC funds in Denmark Health Care startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Health Care VC Funds in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 370 VC funds investing in Denmark Health Care startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists